Address
MPM Capital
601 Gateway Boulevard
Suite 350
South San Francisco, CA 94080
United States
Phone
Email
Website
Recent investment activity
KANDO id: 30789
Relation
Renamed to
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 26 - 50 of 71| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
EndoGastric Solutions Inc | Series B | ||||
|
|
Rinat Neuroscience Corp | Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseases | Series B Initial investment | |||
|
|
EndoGastric Solutions Inc | Series A | ||||
|
|
Omrix Biopharmaceuticals Inc | N/A | ||||
|
|
Cellerant Therapeutics Inc | Biotechnology company with a portfolio of products based on the regulation of the hematopoietic (blood-forming) system. | N/A | |||
|
Arena Pharmaceuticals Inc | N/A | ||||
|
|
Cerimon Pharmaceuticals Inc | Biopharmaceutical company dedicated to bringing innovative therapeutics to patients with substantial, unmet medical needs. | N/A | |||
|
|
CGI Pharmaceuticals Inc | A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. | N/A | |||
|
|
Quantum Dot Corp | N/A | ||||
|
|
Acorda Therapeutics Inc | A biotechnology company whose mission is to develop and market therapeutic products for spinal cord injury and other central nervous system disorders. | N/A | |||
|
|
Sonic Innovations Inc | N/A | ||||
|
|
Eyetech Pharmaceuticals Inc | Biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. | N/A | |||
|
|
Allos Therapeutics Inc | N/A | ||||
|
|
Alnara Pharmaceuticals Inc | N/A | ||||
|
|
BioMarin Pharmaceutical Inc | N/A | ||||
|
|
Keryx Biopharmaceuticals Inc | N/A | ||||
|
|
EnteroMedics Inc | Develops therapeutic devices for the treatment of obesity. Its VSM technology uses electrical signals, delivered by an implantable electrode array, to | N/A | |||
|
|
CryoCor Inc | N/A | ||||
|
|
Orexigen Therapeutics Inc | N/A | ||||
|
|
Rhythm Pharmaceuticals Inc | Series A | ||||
|
|
Portola Pharmaceuticals Inc | N/A | ||||
|
|
Valeritas Inc | N/A | ||||
|
23andMe Inc | DNA testing and genome sequencing firm. | Series D Initial investment | |||
|
|
IDUN Pharmaceuticals Inc | N/A |
| Company | Profile | Funding | ||
|---|---|---|---|---|
|
|
CODA Biotherapeutics | N/A Initial investment Exited Write-off |